论文信息 - Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study - 字舞流文

Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study

G. Burmester | J. Smolen | B. Haraoui | J. Curtis | B. Combe | R. Fleischmann | S. Hall | R. Vollenhoven | L. Peterson | C. Cioffi | L. Ionescu | L. Gervitz | C. Ecoffet